Medicine Information brought to you by discount drugs     and med4.com    

Bextra and Vioxx Withdrawal Spawn Advertising Pause from Bristol Myers


Pharmaceutical giant Bristol Myers Squibb has announced that they will suspend direct-to-consumer advertising for their prescription drug products for a year. This comes in the wake of the well-publicized withdrawals of Merck's Vioxx and Pfizer's Bextra, two non-steroidal anti-inflammatory drugs (NSAIDs) that were voluntarily withdrawn from the market recently. Studies showed that they increase the likelihood of strokes and heart attacks among patients that take them for prolonged periods of time. This represents an unusual move for a pharmaceutical company, as they tend to spend a large portion of their annual advertising budget on direct-to-consumer advertising.

It is possible that Bristol Myers recognizes that consumers are becoming concerned about new drugs being approved by the FDA and advertised heavily, only to find out later that the drugs have previously unknown and possibly dangerous side effects. Consumers have learned that advertising a drug as "new and improved" doesn't necessarily mean that it is new, or improved, or even safe. In short, customers are suspicious of pharmaceutical advertising, and the drug companies are to be commended for taking notice of that fact.

Since 1997, drug companies have been allowed by U.S. law to advertise directly to consumers. This has led to an astonishing number of ads on television and radio, as consumers see ads showing one happy person after another. The ads suggest that the happiness shown is a result of the use of the product, and a voiceover quickly mumbles through the known, and sometimes lengthy, list of side effects. Patients are encouraged to speak with their doctor, and they have been doing so in record numbers. The problem, as Bristol Myers know realizes, is that consumers are well aware that the withdrawn Bextra and Vioxx were advertised as being safe. This has naturally led to a general suspicion of all advertised drugs, and Bristol Myers correctly sees that they could be the victims of a drug-company backlash, even if they didn't manufacture any of the withdrawn products.

This will probably save Bristol Myers a lot of money in the short term, as their advertising would have largely gone to waste. The Food and Drug Administration is taking steps to make sure that the drugs that reach the U.S. market are safe, and in time, the public will again become more trusting of pharmaceutical advertising. In the meantime, TV viewers will be spared from having to watch the sometimes-cryptic drug ads, which often prompt questions of "What does this drug do?"

©Copyright 2005 by Retro Marketing.

Charles Essmeier is the owner of Retro Marketing, a firm devoted to informational Websites, including Bextra-Info.net, a site devoted to the withdrawn drug Bextra and StructuredSettlementHelp.com, a site devoted to structured settlements.


MORE RESOURCES:

National Academy of Sports Medicine Launches New Course ...
MarketWatch - 15 hours ago
CALABASAS, CA, Nov 21, 2008 (MARKET WIRE via COMTEX) -- The National Academy of Sports Medicine (NASM; www.nasm.org), a leader in fitness training ...


Radio Australia

Detroit prepares to swallow some bitter medicine
Financial Times, UK - 2 hours ago
By Bernard Simon in Los Angeles Among the many conditions imposed on Chrysler by Washington in the bail-out of 1979, none is said to have angered the ...
United States needs to help automakers Vineland Daily Journal
all 678 news articles


University of South Alabama College of Medicine Chooses MDaudit(TM)
MarketWatch - 10 hours ago
... WIRE) -- Hayes Management Consulting announced today that it will provide its MDaudit(TM) software to University of South Alabama College of Medicine. ...


MinuteClinic co-founder launches e-medicine startup
Bizjournals.com, NC - 3 hours ago
Nearly a decade after he came up with the idea that became MinuteClinic, Rick Krieger thinks he’s come across a new way to change health care. ...


WNCT

Three Employees Fired After Patient Chokes on Medicine, Dies
FOXNews - Nov 20, 2008
GOLDSBORO, NC — North Carolina officials have fired three employees and disciplined others in the death of a patient who was neglected for more than 22 ...
Firings a good first step in neglect case CharlotteObserver.com
all 38 news articles


PR Web (press release)

BodyLogicMD Sponsors American Academy of Anti-Aging Medicine
MarketWatch - 23 hours ago
"It is a natural step for BodyLogicMD in terms of demonstrating our growth and support in the field of anti-aging medicine and bioidentical hormone therapy. ...
BodyLogicMD Opens Bioidentical Hormone Therapy Location in Chicago PR Web (press release)
all 12 news articles


Entry Level Finding Ways to Help Children With Cancer
New York Times, United States - 12 hours ago
She comes to the job with a master’s degree in Oriental medicine from Touro College and a lifelong love of cooking. On doing acupuncture on small children: ...


Tongjitang Chinese Medicines Company to Announce Third Quarter ...
FOXBusiness - 11 hours ago
Tongjitang Chinese Medicines Company, through its operating subsidiaries Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores, ...


Research and Markets: This Global Research Report in Medicine and ...
MarketWatch - Nov 19, 2008
Nanomaterials, nanophotonics, nanoelectronics and nanoscience in medicine & biology represent the largest concentration of R&D. ...


Overworked doctors would not recommend careers in medicine
SmartBrief, DC - 9 hours ago
A survey of primary care doctors indicates most feel overworked and would not recommend medicine as a career. Nearly half the doctors who responded to the ...

Medicine - Google News

home | site map
© 2006